Eaton Vance Management Makes New Investment in ZimVie Inc. (NASDAQ:ZIMV)

Eaton Vance Management bought a new position in ZimVie Inc. (NASDAQ:ZIMVGet Rating) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 18,650 shares of the company’s stock, valued at approximately $185,000. Eaton Vance Management owned approximately 0.07% of ZimVie at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Point72 Hong Kong Ltd purchased a new stake in ZimVie in the third quarter worth approximately $27,000. US Bancorp DE bought a new position in shares of ZimVie during the third quarter valued at approximately $36,000. Zurcher Kantonalbank Zurich Cantonalbank bought a new position in shares of ZimVie during the third quarter valued at approximately $46,000. Strs Ohio bought a new position in shares of ZimVie during the third quarter valued at approximately $47,000. Finally, Tower Research Capital LLC TRC bought a new position in shares of ZimVie during the third quarter valued at approximately $47,000. Hedge funds and other institutional investors own 74.29% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Barclays decreased their target price on ZimVie from $9.00 to $5.00 and set an “underweight” rating for the company in a report on Monday.

ZimVie Stock Performance

ZIMV opened at $5.53 on Wednesday. The stock has a fifty day simple moving average of $9.48 and a two-hundred day simple moving average of $10.07. The company has a current ratio of 2.48, a quick ratio of 1.40 and a debt-to-equity ratio of 0.73. ZimVie Inc. has a 12-month low of $5.05 and a 12-month high of $28.94.

ZimVie Company Profile

(Get Rating)

ZimVie Inc, a medical technology company, develops, manufactures, and delivers a portfolio of products and solutions designed to treat a range of spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; bone grafts, barrier membranes, allografts, and collagen wound care products; intraoral scanners; and virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and patient-specific restorative components and intra-oral scanners, as well as spinal fusion implants and instrumentation for various spinal procedures, biologics, and bone healing technologies.

Further Reading

Want to see what other hedge funds are holding ZIMV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ZimVie Inc. (NASDAQ:ZIMVGet Rating).

Institutional Ownership by Quarter for ZimVie (NASDAQ:ZIMV)

Receive News & Ratings for ZimVie Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZimVie and related companies with MarketBeat.com's FREE daily email newsletter.